Purpose: Neurofibromatosis type 2 (NF2) and schwannomatosis (SWN) are genetically distinct tumor predisposition syndromes with overlapping phenotypes. We sought to update the diagnostic criteria for NF2 and SWN by incorporating recent advances in genetics, ophthalmology, neuropathology, and neuroimaging. Methods: We used a multistep process, beginning with a Delphi method involving global disease experts and subsequently involving non-neurofibromatosis clinical experts, patients, and foundations/patient advocacy groups. Results: We reached consensus on the minimal clinical and genetic criteria for diagnosing NF2 and SWN. These criteria incorporate mosaic forms of these conditions. In addition, we recommend updated nomenclature for these disorders to emphasize their phenotypic overlap and to minimize misdiagnosis with neurofibromatosis type 1. Conclusion: The updated criteria for NF2 and SWN incorporate clinical features and genetic testing, with a focus on using molecular data to differentiate the 2 conditions. It is likely that continued refinement of these new criteria will be necessary as investigators study the diagnostic properties of the revised criteria and identify new genes associated with SWN. In the revised nomenclature, the term "neurofibromatosis 2" has been retired to improve diagnostic specificity.

Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation / Scott R Plotkin , Ludwine Messiaen , Eric Legius , Patrice Pancza , Robert A Avery , Jaishri O Blakeley , Dusica Babovic-Vuksanovic , Rosalie Ferner , Michael J Fisher , Jan M Friedman , Marco Giovannini , David H Gutmann , Clemens Oliver Hanemann , Michel Kalamarides , Hildegard Kehrer-Sawatzki , Bruce R Korf , Victor-Felix Mautner , Mia MacCollin , Laura Papi , Katherine A Rauen , Vincent Riccardi , Elizabeth Schorry , Miriam J Smith , Anat Stemmer-Rachamimov , David A Stevenson , Nicole J Ullrich , David Viskochil , Katharina Wimmer , Kaleb Yohay ; International Consensus Group on Neurofibromatosis Diagnostic Criteria (I-NF-DC); Susan M Huson , Pierre Wolkenstein , D Gareth Evans. - In: GENETICS IN MEDICINE. - ISSN 1530-0366. - ELETTRONICO. - 24:(2022), pp. 1967-1977. [10.1016/j.gim.2022.05.007]

Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation

Laura Papi
Formal Analysis
;
2022

Abstract

Purpose: Neurofibromatosis type 2 (NF2) and schwannomatosis (SWN) are genetically distinct tumor predisposition syndromes with overlapping phenotypes. We sought to update the diagnostic criteria for NF2 and SWN by incorporating recent advances in genetics, ophthalmology, neuropathology, and neuroimaging. Methods: We used a multistep process, beginning with a Delphi method involving global disease experts and subsequently involving non-neurofibromatosis clinical experts, patients, and foundations/patient advocacy groups. Results: We reached consensus on the minimal clinical and genetic criteria for diagnosing NF2 and SWN. These criteria incorporate mosaic forms of these conditions. In addition, we recommend updated nomenclature for these disorders to emphasize their phenotypic overlap and to minimize misdiagnosis with neurofibromatosis type 1. Conclusion: The updated criteria for NF2 and SWN incorporate clinical features and genetic testing, with a focus on using molecular data to differentiate the 2 conditions. It is likely that continued refinement of these new criteria will be necessary as investigators study the diagnostic properties of the revised criteria and identify new genes associated with SWN. In the revised nomenclature, the term "neurofibromatosis 2" has been retired to improve diagnostic specificity.
2022
24
1967
1977
Scott R Plotkin , Ludwine Messiaen , Eric Legius , Patrice Pancza , Robert A Avery , Jaishri O Blakeley , Dusica Babovic-Vuksanovic , Rosalie Ferner , Michael J Fisher , Jan M Friedman , Marco Giovannini , David H Gutmann , Clemens Oliver Hanemann , Michel Kalamarides , Hildegard Kehrer-Sawatzki , Bruce R Korf , Victor-Felix Mautner , Mia MacCollin , Laura Papi , Katherine A Rauen , Vincent Riccardi , Elizabeth Schorry , Miriam J Smith , Anat Stemmer-Rachamimov , David A Stevenson , Nicole J Ullrich , David Viskochil , Katharina Wimmer , Kaleb Yohay ; International Consensus Group on Neurofibromatosis Diagnostic Criteria (I-NF-DC); Susan M Huson , Pierre Wolkenstein , D Gareth Evans
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1098360022007730-main.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 540.74 kB
Formato Adobe PDF
540.74 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1354164
Citazioni
  • ???jsp.display-item.citation.pmc??? 36
  • Scopus 68
  • ???jsp.display-item.citation.isi??? 62
social impact